Karol Gutowski
Plastic Surgery · Glenview, ILNPI 1134198799
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Merz North America, Inc. accounts for 70.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $29,525 and has fallen 67.8% since, to $9,507 in 2025. Among plastic surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $408.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$37K
- Integra Lifesciences Corporation$9K
- AbbVie$3K
- Surgical Innovation Associates, Inc.$3K
- Covidien LP$420
- C. R. Bard, Inc. & Subsidiaries$227
- plus $882 from 13 others
What the payments were for
- Consulting fees$23,92545%
- Speaking & faculty fees$13,12225%
- Travel & lodging$8,53916%
- Food & beverage$4,6259%
- Education$2650%
- Other$2,5875%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 88 | $37,211 |
| Integra Lifesciences Corporation | 2 | $9,011 |
| AbbVie(2 entities) | 16 | $2,725 |
| Surgical Innovation Associates, Inc. | 2 | $2,587 |
| Covidien LP | 1 | $420 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $227 |
| Bard Peripheral Vascular, Inc. | 1 | $144 |
| Kerecis Limited | 2 | $138 |
| Vertex | 1 | $131 |
| TELA Bio, Inc. | 2 | $107 |
| RTI Surgical, Inc | 1 | $83 |
| Galderma Laboratories, L.p. | 4 | $57 |
| Medtronic | 1 | $50 |
| Sientra, Inc. | 2 | $44 |
| Mentor Worldwide LLC | 2 | $28 |
| Heron Therapeutics, Inc. | 1 | $26 |
| Motiva USA, LLC | 1 | $26 |
| Boston Scientific | 1 | $24 |
| Tepha Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$19,848
- OMNIGRAFT$9,000
- INTEGRA$9,000
- DuraSorb Monofilament Mesh$2,587
- Kerecis SurgiClose$467
- LigaSure$420
- NATRELLE SALINE-FILLED BREAST IMPLANTS$126
- Kerecis GraftGuide$117
- ASCLERA$107
How this compares
$53,062 in reported general payments places this provider in the 95th percentile of 191 plastic surgery providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Glenview
- Steven DayanChicago$1.2M
- Saeed ChowdhryOak Lawn$403K
- Marco EllisChicago$225K
- Robert GalianoChicago$123K
- Theresa CamberisArlington Heights$113K
- Michael LeeChicago$109K
- Michael OgilvieOak Lawn$45K
- Renee BurkeHoffman Estates$43K
- Sanjay NaranPark Ridge$36K
- Lawrence IteldChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.